Martin Brenner

Martin Brenner

Chief Executive Officer presso IBIO, INC.

Patrimonio netto: 37 048 $ in data 31/03/2024

54 anni
Health Technology
Consumer Services

Profilo

Martin B.
Brenner
's current job is Chief Executive & Scientific Officer at iBio, Inc. Formerly, Dr. Brenner worked as Senior Director & Head-BioScience at AstraZeneca PLC from 2012 to 2013.
He then served as Executive Director-Diabetes & NASH at Merck Research Laboratories Massachusetts LLC from 2013 to 2016.
Dr. Brenner was also the Head-Insulin Resistance Group at Pfizer Inc. Additionally, he held the position of Chief Scientific Officer at Recursion Pharmaceuticals, Inc. from 2017 to 2018.
From 2019 to 2020, Dr. Brenner worked as Chief Scientific Officer & Senior Vice President at Pfenex, Inc. He also served as VP & Head-Research & Early Development at Stoke Therapeutics, Inc. from 2016 to 2017.
Dr. Brenner obtained a doctorate degree from Ludwig-Maximilians-Universität München.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/11/2023 9 125 ( 0.11% ) 37 048 $ 31/03/2024

Posizioni attive di Martin Brenner

SocietàPosizioneInizio
IBIO, INC. Chief Executive Officer 20/01/2023
Tutte le posizioni attive di Martin Brenner

Precedenti posizioni note di Martin Brenner

SocietàPosizioneFine
PFENEX INC. Chief Tech/Sci/R&D Officer 01/10/2020
RECURSION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/01/2018
STOKE THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2017
Director/Board Member 01/01/2016
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2013
Vedi nel dettaglio l'esperienza di Martin Brenner

Formazione di Martin Brenner

Ludwig-Maximilians-Universität München Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martin Brenner

Relazioni

77

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

RECURSION PHARMACEUTICALS, INC.

Health Technology

IBIO, INC.

Health Technology

STOKE THERAPEUTICS, INC.

Health Technology

Aziende private2

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Martin Brenner